Financhill
Back

Gold Royalty Vs. Novo Nordisk AS Industry Stock Comparison

Sell
17

GROY
Gold Royalty

Last Price:
$1.18
Seasonality Move:
-0.2%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.33
Seasonality Move:
6.58%
Sell
17
Gold Royalty (GROY) is a Sell

Is Gold Royalty a Buy, Sell or Hold?

  • The current Gold Royalty [GROY] share price is $1.17. The Score for GROY is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • GROY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GROY Stock Price Chart

What is Gold Royalty's stock price today?

  • The Gold Royalty share price today is $1.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GROY is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

GROY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 34.45 Sell
Chaikin Money Flow: -359391 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.22 - 1.3) Sell
Bollinger Bands (100): (1.24 - 1.42) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

GROY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.22 Sell
20-day SMA: 1.25 Sell
50-day SMA: 1.34 Sell
200-day SMA: 1.53 Sell
8-day EMA: 1.21 Sell
20-day EMA: 1.25 Sell
50-day EMA: 1.3 Sell
200-day EMA: 1.45 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

Gold Royalty Earnings Growth & GROY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.01 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

Gold Royalty Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):